Wolfe Research Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $285
Danaher Analyst Ratings
Wolfe Research Upgrades Danaher(DHR.US) to Buy Rating, Announces Target Price $285
Danaher Is Maintained at Overweight by Keybanc
Danaher Price Target Raised to $310.00/Share From $290.00 by Keybanc
UBS Adjusts Price Target on Danaher to $305 From $309, Maintains Buy Rating
Danaher Analyst Ratings
Danaher (DHR) Gets a Hold From Barclays
Goldman Sachs Raises Danaher's Price Target to $255 From $250
Barclays Maintains Danaher(DHR.US) With Hold Rating, Maintains Target Price $285
Barclays Sticks to Their Hold Rating for Danaher (DHR)
RBC Capital Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $333
J.P. Morgan Maintains Danaher(DHR.US) With Buy Rating, Raises Target Price to $310
Danaher Is Maintained at Outperform by Evercore ISI Group
Evercore ISI Adjusts Danaher Price Target to $278 From $275
Danaher Initiated at Overweight by Stephens & Co.
Danaher Analyst Ratings
Stephens Initiates Danaher(DHR.US) With Buy Rating, Announces Target Price $315
Deutsche Bank Raises Price Target on Danaher to $285 From $270
Wells Fargo Maintains Danaher(DHR.US) With Hold Rating, Maintains Target Price $280